Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars
Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and oncology therapies.
Search results for "conference"
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by maintaining kidney function over a...
Daewoong Pharmaceutical’s Nabota Enters Kuwait, Expanding Middle East Footprint to Seven Countries
Daewoong Pharmaceutical’s botulinum toxin product Nabota has entered Kuwait, expanding its Middle East footprint to...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology
Daegu has been selected to host the 2034 World Congress of Basic & Clinical Pharmacology (WCP 2034), marking the first...
From Twin Risks to Tylenol Safety: Medical Society Addresses Four Major Pregnancy Concerns
How much does risk escalate during a twin pregnancy? Is cerebral palsy strictly caused by complications during labor...
Japanese Medical Scholars Visit Daegu, Praising South Korea's Advanced Healthcare and Rich Cultural Heritage
South Korea’s advanced medical infrastructure and deep cultural heritage left a lasting impression on prominent figures...
The 8 A.M. Miracle: How Parkside Rehabilitation Hospital Redesigns Lives After Acute Care
Every Wednesday and Friday, Parkside Rehabilitation Hospital—located near the UN Memorial Cemetery in Nam-gu,...
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care
“Lately, I keep forgetting appointments.” “They keep repeating what they just said.” When memory lapses in a parent...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...